MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
173 hedge funds and large institutions have $3.76B invested in Mirati Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 86 increasing their positions, 45 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
32% less capital invested
Capital invested by funds: $5.5B → $3.76B (-$1.74B)
34% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 44
Holders
173
Holding in Top 10
7
Calls
$111M
Puts
$55M
Top Buyers
| 1 | +$87.7M | |
| 2 | +$58.2M | |
| 3 | +$34.3M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$32.7M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$31.5M |
Top Sellers
| 1 | -$33.3M | |
| 2 | -$33.2M | |
| 3 | -$15.9M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$14M |
| 5 |
Morgan Stanley
New York
|
-$8.83M |